文献速递妇科生殖医学

多囊卵巢综合征中脂肪细胞与类固醇生成细胞的交互作用

Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
PubMed 文献 · Hum Reprod Update · 2021-01-01

本综述基于PubMed检索的动物与人类研究,评估多囊卵巢综合征(PCOS)中脂肪细胞与肾上腺及卵巢类固醇生成细胞的相互关系。PCOS女性脂肪因子分泌失衡,表现为瘦素升高、脂联素降低;瘦素与BMI、腰臀比、血脂、LH、雌二醇及雄激素正相关,脂联素与脂肪量、BMI、腰臀比、血糖、胰岛素及甘油三酯负相关。动物模型中高胰岛素血症和生育力低下常见,脂肪因子对卵巢类固醇生成的调节存在物种差异。

要点

  • PCOS女性脂肪因子分泌失衡:瘦素升高、脂联素降低。
  • 瘦素与BMI、腰臀比、血脂、LH、雌二醇及雄激素正相关。
  • 脂联素负性调节类固醇生成,降低雄激素产生。

核心结论

  • 脂肪细胞与类固醇生成细胞在PCOS中存在交互作用,但动物与人类数据存在矛盾。
  • PCOS是研究脂肪细胞与类固醇生成细胞相互关系的良好模型。

研究设计与样本

  • 综述检索PubMed英文和葡萄牙语文献,关键词包括PCOS、类固醇生成、肾上腺、卵泡膜细胞、颗粒细胞、脂肪细胞等,并扩展检索参考文献。

主要发现

  • PCOS女性瘦素水平升高、脂联素水平降低。
  • 瘦素表达与BMI、腰臀比、总胆固醇、甘油三酯、LH、雌二醇及雄激素水平正相关。
  • 脂联素水平与脂肪量、BMI、腰臀比、葡萄糖、胰岛素及甘油三酯负相关。
  • 抵抗素表达与BMI和睾酮正相关,并促进卵泡膜细胞17-羟化酶表达。
  • 动物PCOS模型中高胰岛素血症和生育力低下常见,脂肪因子对卵巢类固醇生成的调节存在物种差异。

临床怎么用

  • 适当情况下可考虑单用二甲双胍或联合氟他胺治疗。
  • 脂肪因子在PCOS治疗中的潜在益处需进一步研究。

局限性

  • 动物与人类关于脂肪细胞产物与类固醇生成细胞关系的数据存在矛盾。
  • 脂肪因子在肥胖和非肥胖PCOS女性中的治疗应用需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metabolic and endocrine alterations in women with polycystic ovary syndrome (PCOS) affect adipose tissue mass and distribution. PCOS is characterised by hyperandrogenism, obesity and adipocyte dysfunction. Hyperandrogenism in PCOS drives dysfunctional adipocyte secretion of potentially harmful adipocytokines. Glucocorticoids and sex-steroids modulate adipocyte development and function. For their part, adipocyte products interact with adrenal and ovarian steroidogenic cells. Currently, the relationship between adipocyte and steroidogenic cells is not clear, and for these reasons, it is important to elucidate the interrelationship between these cells in women with and without PCOS. OBJECTIVE AND RATIONALE: This comprehensive review aims to assess current knowledge regarding the interrelationship between adipocytes and adrenal and ovarian steroidogenic cells in animal models and humans with or without PCOS. SEARCH METHODS: We searched for articles published in English and Portuguese in PubMed. Keywords were as follows: polycystic ovary syndrome, steroidogenesis, adrenal glands, theca cells, granulosa cells, adipocytes, adipocytokines, obesity, enzyme activation, and cytochrome P450 enzymes. We expanded the search into the references from the retrieved articles. OUTCOMES: Glucocorticoids and sex-steroids modulate adipocyte differentiation and function. Dysfunctional adipocyte products play important roles in the metabolic and endocrine pathways in animals and women with PCOS. Most adipokines participate in the regulation of the hypothalamic-pituitary-adrenal and ovarian axes. In animal models of PCOS, hyperinsulinemia and poor fertility are common; various adipokines modulate ovarian steroidogenesis, depending on the species. Women with PCOS secrete unbalanced levels of adipocyte products, characterised by higher levels of leptin and lower levels of adiponectin. Leptin expression positively correlates with body mass index, waist/hip ratio and levels of total cholesterol, triglyceride, luteinising hormone, oestradiol and androgens. Leptin inhibits the production of oestradiol and, in granulosa cells, may modulate 17-hydroxylase and aromatase enzyme activities. Adiponectin levels negatively correlate with fat mass, body mass index, waist-hip ratio, glucose, insulin and triglycerides, and decrease androgen production by altering expression of luteinising hormone receptor, steroidogenic acute regulatory protein, cholesterol-side-chain cleavage enzyme and 17-hydroxylase. Resistin expression positively correlates with body mass index and testosterone, and promotes the expression of 17-hydroxylase enzyme in theca cells. The potential benefits of adipokines in the treatment of women with PCOS require more investigation. WIDER IMPLICATIONS: The current data regarding the relationship between adipocyte products and steroidogenic cells are conflicting in animals and humans. Polycystic ovary syndrome is an excellent model to investigate the interrelationship among adipocyte and steroidogenic cells. Women with PCOS manifest some pathological conditions associated with hyperandrogenism and adipocyte products. In animals, cross-talk between cells may vary according to species, and the current review suggests opportunities to test new medications to prevent or even reverse several harmful sequelae of PCOS in humans. Further studies are required to investigate the possible therapeutic application of adipokines in women with obese and non-obese PCOS. Meanwhile, when appropriate, metformin use alone, or associated with flutamide, may be considered for therapeutic purposes.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. de Medeiros SF, Rodgers RJ, Norman RJ, et al. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome. Hum Reprod Update. 2021. PMID: 33764457. doi:10.1093/humupd/dmab004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。